Vaccines for Cancer
Cancer vaccines for multiple types of cancer have been currently under investing.
This follows development of safe vaccine delivery technologies, and identification of more than 2000 immunogenic tumor proteins.
It is observed that the adverse effects associated with cancer vaccines are generally mild and of short duration.
These developments promote the eventual integration of vaccination into treatment regimens with chemotherapy and immunotherapy.
